45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
16,705
Insurances with rates
52
CPT / HCPCS codes
11,117
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 50881-012-10 | AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION | $78,750 | $31,500 | — | — | 0 |
| 58468-0200-1 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION | $73,624 | $24,541 | — | — | 0 |
| 72694-515-01 | CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION | $72,590 | $5,807 | — | — | 0 |
| 0024-5824-11 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $37,577 | $15,031 | — | — | 0 |
| 51144-050-01 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION (DESENSITIZATION) | $36,600 | $14,640 | — | — | 0 |
| 50881-023-11 | AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION | $34,650 | $31,500 | — | — | 0 |
| 50242-917-01 | ATEZOLIZUMAB 1 200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $33,755 | $675 | — | — | 0 |
| 61755-008-01 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $32,775 | $1,873 | — | — | 0 |
| 68727-745-01 | DAUNORUBICIN 44 MG AND CYTARABINE 100 MG IN LIPOSOME IV SOLUTION | $32,303 | $12,921 | — | — | 0 |
| 57894-503-01 | DARATUMUMAB 1 800 MG-HYALURONIDASE-FIHJ 30 000 UNIT/15 ML SUBCUT SOLN | $31,716 | $846 | — | — | 0 |
| 0173-0896-01 | BELANTAMAB MAFODOTIN-BLMF 100 MG INTRAVENOUS SOLUTION | $26,479 | $10,592 | — | — | 0 |
| 50242-085-25 | ALTEPLASE 100 MG INTRAVENOUS SOLUTION | $26,401 | $10,560 | — | — | 0 |
| 50242-085-27 | ALTEPLASE 100 MG INTRAVENOUS SOLUTION | $26,401 | $10,560 | — | — | 0 |
| 58468-0225-1 | CAPLACIZUMAB-YHDP 11 MG INJECTION KIT | $25,715 | $10,286 | — | — | 0 |
| 58468-0227-1 | CAPLACIZUMAB-YHDP 11 MG SOLUTION FOR INJECTION | $25,715 | $10,286 | — | — | 0 |
| 69932-002-01 | FLOTUFOLASTAT F 18 GALLIUM 296-5 846 MBQ/ML (8-158 MCI/ML) IV SOLUTION | $22,796 | $5,066 | — | — | 0 |
| 50242-918-01 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION | $22,054 | $630 | — | — | 0 |
| 50242-087-01 | ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION | $19,150 | $7,660 | — | — | 0 |
| 55513-150-01 | BLINATUMOMAB 35 MCG INTRAVENOUS SOLUTION | $16,670 | $6,668 | — | — | 0 |
| 76310-022-01 | ALDESLEUKIN 22 MILLION UNIT INTRAVENOUS SOLUTION | $16,654 | $6,662 | — | — | 0 |
| 69945-064-01 | COPPER CU-64 DOTATATE 148 MBQ/4 ML (4 MCI/4 ML) INTRAVENOUS SOLUTION | $16,524 | $3,672 | — | — | 0 |
| 73607-011-11 | ARTESUNATE 110 MG INTRAVENOUS SOLUTION | $16,136 | $6,454 | — | — | 0 |
| 73607-002-01 | ARTESUNATE 110 MG INTRAVENOUS SOLUTION | $16,136 | $6,454 | — | — | 0 |
| 0310-3040-00 | ANIFROLUMAB-FNIA 300 MG/2 ML (150 MG/ML) INTRAVENOUS SOLUTION | $16,002 | $3,200 | — | — | 0 |
| 68727-900-01 | ASPARAGINASE ERWINIA CHRYSANTHEMI-RYWN 10 MG/0.5 ML IM SOLUTION | $15,700 | $12,560 | — | — | 0 |
| 50242-044-06 | ALTEPLASE INFUSION - STROKE (DOSES </= 45 MG) | $13,201 | $5,280 | — | — | 0 |
| 50242-044-13 | ALTEPLASE IV BOLUS - STROKE (DOSES </= 5 MG) | $13,201 | $5,280 | — | — | 0 |
| 51144-030-01 | ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION | $12,641 | $5,056 | — | — | 0 |
| 0310-4611-50 | DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION | $12,631 | $505 | — | — | 0 |
| 50242-088-01 | ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION | $11,969 | $4,788 | — | — | 0 |
| 57894-501-00 | AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION | $11,420 | $653 | — | — | 0 |
| 42023-157-01 | ETHACRYNATE SODIUM 50 MG INTRAVENOUS SOLUTION | $11,400 | $4,560 | — | — | 0 |
| 00000-0000-83 | COBALT-57 20 MICRO CI | $11,088 | $2,464 | — | — | 0 |
| 0024-5860-01 | CLOFARABINE 1 MG/ML INTRAVENOUS SOLUTION | $10,693 | $214 | — | — | 0 |
| 76075-101-01 | CARFILZOMIB 60 MG INTRAVENOUS SOLUTION | $10,612 | $4,245 | — | — | 0 |
| 0074-0243-02 | ADALIMUMAB 40 MG/0.4 ML SUBCUTANEOUS SYRINGE KIT | $10,384 | $4,154 | — | — | 0 |
| 55513-730-01 | DENOSUMAB 120 MG/1.7 ML (70 MG/ML) SUBCUTANEOUS SOLUTION | $10,349 | $2,435 | — | — | 0 |
| 50242-061-01 | BEVACIZUMAB 25 MG/ML INJECTION (ENT) | $10,201 | $255 | — | — | 0 |
| 42367-540-32 | DANTROLENE 250 MG INTRAVENOUS SUSPENSION | $9,943 | $3,977 | — | — | 0 |
| 70121-1755-1 | BEVACIZUMAB-MALY 25 MG/ML INTRAVENOUS SOLUTION | $9,198 | $230 | — | — | 0 |
| 70121-1755-7 | BEVACIZUMAB-MALY 25 MG/ML INTRAVENOUS SOLUTION | $9,198 | $230 | — | — | 0 |
| 0003-4522-11 | ELOTUZUMAB 400 MG INTRAVENOUS SOLUTION | $9,103 | $3,641 | — | — | 0 |
| 66658-501-01 | EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION | $9,079 | $1,816 | — | — | 0 |
| 55513-207-01 | BEVACIZUMAB-AWWB 25 MG/ML INTRAVENOUS SOLUTION | $8,931 | $223 | — | — | 0 |
| 57894-502-20 | DARATUMUMAB 20 MG/ML INTRAVENOUS SOLUTION | $8,824 | $176 | — | — | 0 |
| 65597-406-01 | FAM-TRASTUZUMAB DERUXTECAN-NXKI 100 MG INTRAVENOUS SOLUTION | $8,804 | $3,522 | — | — | 0 |
| 72606-012-01 | BEVACIZUMAB-ADCD 25 MG/ML INTRAVENOUS SOLUTION | $8,671 | $217 | — | — | 0 |
| 49411-052-08 | AMINOCAPROIC ACID 250 MG/ML (25 %) ORAL SOLUTION | $8,263 | $13.98 | — | — | 0 |
| 55292-811-55 | DACTINOMYCIN 0.5 MG INTRAVENOUS SOLUTION | $8,126 | $3,250 | — | — | 0 |
| 67457-546-20 | CLOFARABINE 1 MG/ML INTRAVENOUS SOLUTION | $7,915 | $158 | — | — | 0 |
Showing top 50 of 16,705 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.